The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Delivery > Dimethaid Research Inc.

Dimethaid Research Inc.
 PROFILE
Dimethaid Research makes site-specific delivery systems that administer therapeutic drugs through the skin. The company believes its technology works with minimal side effects to other parts of the body by targeting only the affected area. It is developing PENNSAID, a lotion that targets arthritis pain; the company has filed for marketing approval of the drug in Canada, the US, and the UK. Another product using the company's technology is being developed by Swiss firm Oxo Chemie (of which Dimethaid owns some 20%), and is intended to modulate abnormal immune response in HIV/AIDS and cancer patients. Subsidiary Dioptic Laboratories makes branded and generic eye care products.

 COMPETITION
Elan Corporation, plc (ELN)
LecTec Corporation (LECT)
MacroChem Corporation (MCHM)

 FINANCIAL OVERVIEW
Fiscal Year-End: May
1999 Sales (mil.): 0.80
1-Yr. Sales Growth: 5.0%
Employees: 39
Revenue per employee: $20,512.82

 KEY PEOPLE
• Rebecca E. Keeler
    CEO

 CONTACT INFO
1405 Denison St.
Markham Ontario L3R 5V2, Canada
Phone: 1-905-415-1446
Fax: 1-905-415-1440
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001